BSX logo

Boston Scientific (BSX) Revenue

Annual revenue:

$16.75B+$2.51B(+17.61%)
December 1, 2024

Summary

  • As of today (April 13, 2025), BSX annual revenue is $16.75 billion, with the most recent change of +$2.51 billion (+17.61%) on December 1, 2024.
  • During the last 3 years, BSX annual revenue has risen by +$4.86 billion (+40.87%).
  • BSX annual revenue is now at all-time high.

Performance

BSX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

Quarterly revenue:

$4.56B+$352.00M(+8.36%)
December 1, 2024

Summary

  • As of today (April 13, 2025), BSX quarterly revenue is $4.56 billion, with the most recent change of +$352.00 million (+8.36%) on December 1, 2024.
  • Over the past year, BSX quarterly revenue has stayed the same.
  • BSX quarterly revenue is now at all-time high.

Performance

BSX Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

TTM revenue:

$16.75B+$836.00M(+5.25%)
December 1, 2024

Summary

  • As of today (April 13, 2025), BSX TTM revenue is $16.75 billion, with the most recent change of +$836.00 million (+5.25%) on December 1, 2024.
  • Over the past year, BSX TTM revenue has stayed the same.
  • BSX TTM revenue is now at all-time high.

Performance

BSX TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

BSX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.6%0.0%0.0%
3 y3 years+40.9%0.0%0.0%
5 y5 years+56.0%0.0%0.0%

BSX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+40.9%at high+50.7%at high+37.7%
5 y5-yearat high+68.9%at high+127.7%at high+68.9%
alltimeall timeat high+7181.3%at high+8931.7%at high>+9999.0%

Boston Scientific Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$16.75B(+17.6%)
$4.56B(+8.4%)
$16.75B(+5.3%)
Sep 2024
-
$4.21B(+2.2%)
$15.91B(+4.5%)
Jun 2024
-
$4.12B(+6.8%)
$15.23B(+3.5%)
Mar 2024
-
$3.86B(+3.5%)
$14.71B(+3.3%)
Dec 2023
$14.24B(+12.3%)
$3.73B(+5.6%)
$14.24B(+3.5%)
Sep 2023
-
$3.53B(-2.0%)
$13.76B(+2.7%)
Jun 2023
-
$3.60B(+6.2%)
$13.40B(+2.7%)
Mar 2023
-
$3.39B(+4.5%)
$13.04B(+2.9%)
Dec 2022
$12.68B(+6.7%)
$3.24B(+2.3%)
$12.68B(+0.9%)
Sep 2022
-
$3.17B(-2.3%)
$12.57B(+1.9%)
Jun 2022
-
$3.24B(+7.2%)
$12.33B(+1.4%)
Mar 2022
-
$3.03B(-3.2%)
$12.16B(+2.3%)
Dec 2021
$11.89B(+19.9%)
$3.13B(+6.7%)
$11.89B(+3.6%)
Sep 2021
-
$2.93B(-4.7%)
$11.47B(+2.4%)
Jun 2021
-
$3.08B(+11.8%)
$11.20B(+10.6%)
Mar 2021
-
$2.75B(+1.6%)
$10.12B(+2.1%)
Dec 2020
$9.91B(-7.7%)
$2.71B(+1.9%)
$9.91B(-1.9%)
Sep 2020
-
$2.66B(+32.8%)
$10.11B(-0.5%)
Jun 2020
-
$2.00B(-21.2%)
$10.16B(-5.8%)
Mar 2020
-
$2.54B(-12.4%)
$10.79B(+0.5%)
Dec 2019
$10.73B(+9.3%)
$2.90B(+7.3%)
$10.73B(+3.3%)
Sep 2019
-
$2.71B(+2.9%)
$10.39B(+3.1%)
Jun 2019
-
$2.63B(+5.5%)
$10.08B(+1.4%)
Mar 2019
-
$2.49B(-2.7%)
$9.94B(+1.2%)
Dec 2018
$9.82B(+8.6%)
$2.56B(+7.0%)
$9.82B(+1.6%)
Sep 2018
-
$2.39B(-3.9%)
$9.67B(+1.8%)
Jun 2018
-
$2.49B(+4.7%)
$9.50B(+2.5%)
Mar 2018
-
$2.38B(-1.2%)
$9.27B(+2.4%)
Dec 2017
$9.05B(+7.9%)
$2.41B(+8.4%)
$9.05B(+2.5%)
Sep 2017
-
$2.22B(-1.6%)
$8.83B(+1.3%)
Jun 2017
-
$2.26B(+4.5%)
$8.71B(+1.5%)
Mar 2017
-
$2.16B(-1.4%)
$8.58B(+2.3%)
Dec 2016
$8.39B(+12.2%)
$2.19B(+4.1%)
$8.39B(+2.6%)
Sep 2016
-
$2.10B(-1.0%)
$8.17B(+2.7%)
Jun 2016
-
$2.13B(+8.2%)
$7.96B(+3.7%)
Mar 2016
-
$1.96B(-0.7%)
$7.67B(+2.6%)
Dec 2015
$7.48B(+1.3%)
$1.98B(+4.8%)
$7.48B(+1.2%)
Sep 2015
-
$1.89B(+2.4%)
$7.39B(+0.6%)
Jun 2015
-
$1.84B(+4.2%)
$7.34B(-0.4%)
Mar 2015
-
$1.77B(-6.3%)
$7.37B(-0.1%)
Dec 2014
$7.38B(+3.3%)
$1.89B(+2.2%)
$7.38B(+0.7%)
Sep 2014
-
$1.85B(-1.4%)
$7.33B(+1.5%)
Jun 2014
-
$1.87B(+5.6%)
$7.22B(+0.9%)
Mar 2014
-
$1.77B(-3.5%)
$7.16B(+0.2%)
Dec 2013
$7.14B(-1.5%)
$1.84B(+5.9%)
$7.14B(+0.2%)
Sep 2013
-
$1.74B(-4.1%)
$7.13B(0.0%)
Jun 2013
-
$1.81B(+2.7%)
$7.13B(-0.3%)
Mar 2013
-
$1.76B(-3.3%)
$7.14B(-1.4%)
Dec 2012
$7.25B(-4.9%)
$1.82B(+5.0%)
$7.25B(-0.4%)
Sep 2012
-
$1.74B(-5.1%)
$7.28B(-1.9%)
Jun 2012
-
$1.83B(-2.0%)
$7.42B(-1.9%)
Mar 2012
-
$1.87B(+1.0%)
$7.56B(-0.8%)
Dec 2011
$7.62B(-2.4%)
$1.85B(-1.4%)
$7.62B(-2.0%)
Sep 2011
-
$1.87B(-5.1%)
$7.78B(-0.5%)
Jun 2011
-
$1.98B(+2.6%)
$7.82B(+0.6%)
Mar 2011
-
$1.93B(-3.8%)
$7.77B(-0.4%)
Dec 2010
$7.81B(-4.7%)
$2.00B(+4.5%)
$7.81B(-1.0%)
Sep 2010
-
$1.92B(-0.6%)
$7.88B(-1.4%)
Jun 2010
-
$1.93B(-1.6%)
$7.99B(-1.8%)
Mar 2010
-
$1.96B(-5.7%)
$8.14B(-0.6%)
Dec 2009
$8.19B(+1.7%)
$2.08B(+2.7%)
$8.19B(+0.9%)
Sep 2009
-
$2.02B(-2.4%)
$8.11B(+0.6%)
Jun 2009
-
$2.07B(+3.2%)
$8.06B(+0.6%)
Mar 2009
-
$2.01B(+0.4%)
$8.01B(-0.4%)
Dec 2008
$8.05B(-3.7%)
$2.00B(+1.2%)
$8.05B(-1.8%)
Sep 2008
-
$1.98B(-2.3%)
$8.20B(-0.8%)
Jun 2008
-
$2.02B(-1.1%)
$8.27B(-0.6%)
Mar 2008
-
$2.05B(-5.0%)
$8.32B(-0.5%)
DateAnnualQuarterlyTTM
Dec 2007
$8.36B(+6.9%)
$2.15B(+5.1%)
$8.36B(+1.1%)
Sep 2007
-
$2.05B(-1.1%)
$8.27B(+0.3%)
Jun 2007
-
$2.07B(-0.7%)
$8.25B(-0.5%)
Mar 2007
-
$2.09B(+1.0%)
$8.29B(+6.0%)
Dec 2006
$7.82B(+24.5%)
$2.06B(+1.9%)
$7.82B(+7.2%)
Sep 2006
-
$2.03B(-4.0%)
$7.30B(+7.6%)
Jun 2006
-
$2.11B(+30.2%)
$6.78B(+7.8%)
Mar 2006
-
$1.62B(+5.2%)
$6.29B(+0.1%)
Dec 2005
$6.28B(+11.7%)
$1.54B(+1.9%)
$6.28B(-0.9%)
Sep 2005
-
$1.51B(-6.6%)
$6.34B(+0.5%)
Jun 2005
-
$1.62B(+0.1%)
$6.31B(+2.5%)
Mar 2005
-
$1.61B(+0.9%)
$6.16B(+9.5%)
Dec 2004
$5.62B(+61.8%)
$1.60B(+8.0%)
$5.62B(+13.3%)
Sep 2004
-
$1.48B(+1.5%)
$4.96B(+13.9%)
Jun 2004
-
$1.46B(+34.9%)
$4.36B(+16.2%)
Mar 2004
-
$1.08B(+15.2%)
$3.75B(+7.9%)
Dec 2003
$3.48B(+19.1%)
$939.00M(+7.2%)
$3.48B(+3.7%)
Sep 2003
-
$876.00M(+2.6%)
$3.35B(+4.8%)
Jun 2003
-
$854.00M(+5.8%)
$3.20B(+4.8%)
Mar 2003
-
$807.00M(-0.9%)
$3.05B(+4.5%)
Dec 2002
$2.92B(+9.2%)
$814.00M(+12.7%)
$2.92B(+4.9%)
Sep 2002
-
$722.00M(+2.0%)
$2.78B(+1.9%)
Jun 2002
-
$708.00M(+4.9%)
$2.73B(+1.3%)
Mar 2002
-
$675.00M(-0.3%)
$2.69B(+0.8%)
Dec 2001
$2.67B(+0.3%)
$677.00M(+1.0%)
$2.67B(+1.5%)
Sep 2001
-
$670.00M(-0.3%)
$2.63B(+0.7%)
Jun 2001
-
$672.00M(+2.8%)
$2.62B(-0.9%)
Mar 2001
-
$654.00M(+2.5%)
$2.64B(-0.9%)
Dec 2000
$2.66B(-6.3%)
$638.00M(-2.1%)
$2.66B(-2.9%)
Sep 2000
-
$652.00M(-6.2%)
$2.74B(-1.4%)
Jun 2000
-
$695.00M(+2.4%)
$2.78B(-1.1%)
Mar 2000
-
$679.00M(-5.3%)
$2.81B(-1.0%)
Dec 1999
$2.84B(+27.2%)
$717.00M(+3.8%)
$2.84B(0.0%)
Sep 1999
-
$691.00M(-4.8%)
$2.84B(+4.2%)
Jun 1999
-
$726.00M(+2.5%)
$2.73B(+9.6%)
Mar 1999
-
$708.00M(-1.3%)
$2.49B(+11.4%)
Dec 1998
$2.23B(+22.0%)
$717.00M(+24.5%)
$2.23B(+13.5%)
Sep 1998
-
$576.00M(+18.0%)
$1.97B(+5.4%)
Jun 1998
-
$488.00M(+7.7%)
$1.87B(+0.8%)
Mar 1998
-
$453.00M(+0.2%)
$1.85B(+1.2%)
Dec 1997
$1.83B(+18.0%)
$451.90M(-4.8%)
$1.83B(+1.1%)
Sep 1997
-
$474.80M(+0.2%)
$1.81B(+4.6%)
Jun 1997
-
$473.70M(+10.0%)
$1.73B(+5.8%)
Mar 1997
-
$430.50M(-0.5%)
$1.64B(+7.1%)
Dec 1996
$1.55B(+30.3%)
$432.60M(+9.3%)
$1.53B(-5.1%)
Sep 1996
-
$395.80M(+4.4%)
$1.61B(+11.2%)
Jun 1996
-
$379.20M(+17.6%)
$1.45B(+11.7%)
Mar 1996
-
$322.40M(-37.4%)
$1.30B(+9.0%)
Dec 1995
$1.19B(+165.2%)
$515.00M(+121.2%)
$1.19B(+49.3%)
Sep 1995
-
$232.80M(+2.4%)
$797.50M(+17.8%)
Jun 1995
-
$227.30M(+5.4%)
$676.90M(+21.0%)
Mar 1995
-
$215.70M(+77.2%)
$559.50M(+24.6%)
Dec 1994
$449.00M(+18.1%)
$121.70M(+8.5%)
$449.10M(+4.8%)
Sep 1994
-
$112.20M(+2.1%)
$428.50M(+4.0%)
Jun 1994
-
$109.90M(+4.4%)
$411.90M(+3.9%)
Mar 1994
-
$105.30M(+4.2%)
$396.40M(+4.3%)
Dec 1993
$380.10M(+20.6%)
$101.10M(+5.8%)
$380.00M(+4.6%)
Sep 1993
-
$95.60M(+1.3%)
$363.30M(+3.9%)
Jun 1993
-
$94.40M(+6.2%)
$349.60M(+5.5%)
Mar 1993
-
$88.90M(+5.3%)
$331.50M(+5.2%)
Dec 1992
$315.20M(+37.0%)
$84.40M(+3.1%)
$315.20M(+7.0%)
Sep 1992
-
$81.90M(+7.3%)
$294.60M(+8.1%)
Jun 1992
-
$76.30M(+5.1%)
$272.60M(+8.1%)
Mar 1992
-
$72.60M(+13.8%)
$252.20M(+9.6%)
Dec 1991
$230.00M
$63.80M(+6.5%)
$230.10M(+38.4%)
Sep 1991
-
$59.90M(+7.2%)
$166.30M(+56.3%)
Jun 1991
-
$55.90M(+10.7%)
$106.40M(+110.7%)
Mar 1991
-
$50.50M
$50.50M

FAQ

  • What is Boston Scientific annual revenue?
  • What is the all time high annual revenue for Boston Scientific?
  • What is Boston Scientific annual revenue year-on-year change?
  • What is Boston Scientific quarterly revenue?
  • What is the all time high quarterly revenue for Boston Scientific?
  • What is Boston Scientific quarterly revenue year-on-year change?
  • What is Boston Scientific TTM revenue?
  • What is the all time high TTM revenue for Boston Scientific?
  • What is Boston Scientific TTM revenue year-on-year change?

What is Boston Scientific annual revenue?

The current annual revenue of BSX is $16.75B

What is the all time high annual revenue for Boston Scientific?

Boston Scientific all-time high annual revenue is $16.75B

What is Boston Scientific annual revenue year-on-year change?

Over the past year, BSX annual revenue has changed by +$2.51B (+17.61%)

What is Boston Scientific quarterly revenue?

The current quarterly revenue of BSX is $4.56B

What is the all time high quarterly revenue for Boston Scientific?

Boston Scientific all-time high quarterly revenue is $4.56B

What is Boston Scientific quarterly revenue year-on-year change?

Over the past year, BSX quarterly revenue has changed by $0.00 (0.00%)

What is Boston Scientific TTM revenue?

The current TTM revenue of BSX is $16.75B

What is the all time high TTM revenue for Boston Scientific?

Boston Scientific all-time high TTM revenue is $16.75B

What is Boston Scientific TTM revenue year-on-year change?

Over the past year, BSX TTM revenue has changed by $0.00 (0.00%)
On this page